↓ Skip to main content

Early Diagnosis and Treatment of Postoperative Endoscopic Recurrence of Crohn’s Disease: Partial Benefit by Infliximab—A Pilot Study

Overview of attention for article published in Digestive Diseases and Sciences, January 2012
Altmetric Badge

Citations

dimensions_citation
73 Dimensions

Readers on

mendeley
64 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Early Diagnosis and Treatment of Postoperative Endoscopic Recurrence of Crohn’s Disease: Partial Benefit by Infliximab—A Pilot Study
Published in
Digestive Diseases and Sciences, January 2012
DOI 10.1007/s10620-011-2025-z
Pubmed ID
Authors

Dario Sorrentino, Giovanni Terrosu, Alberto Paviotti, Marco Geraci, Claudio Avellini, Giorgio Zoli, Walter Fries, Silvio Danese, Pietro Occhipinti, Tiziano Croatto, Dimitra Zarifi

Abstract

Current data indicate that infliximab-given immediately after surgery-may be very effective in preventing postsurgical recurrence of Crohn's disease. However, it is unknown whether a similar benefit would result from early diagnosis and treatment, rather than prevention of endoscopic recurrence.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 64 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Chile 1 2%
United States 1 2%
Brazil 1 2%
Unknown 61 95%

Demographic breakdown

Readers by professional status Count As %
Student > Postgraduate 9 14%
Researcher 8 13%
Professor > Associate Professor 5 8%
Student > Master 5 8%
Student > Bachelor 5 8%
Other 17 27%
Unknown 15 23%
Readers by discipline Count As %
Medicine and Dentistry 38 59%
Computer Science 2 3%
Agricultural and Biological Sciences 2 3%
Immunology and Microbiology 1 2%
Unknown 21 33%